3[4]Sturesson C, Artursson P, Ghaderi R, et al. Encapsulation of rotavirus into poly(lactide-co-glycol-ide) microsphere. J Controlled Release, 1999,59 (3): 377.
4[6]Hedemi Taoka, Etsuko Ogawa, Masao Takahashi. Formation of W/O type microemulsions in biocompatible surfacetant systems 日本油化学会志, 1997,46(12): 1475.
5钟信.Elan公司重视定时治疗药研究[J].国外药讯,1997,(2):38.
6[8]Cevc G, Blume G, Schatzlein A. Transfersomes-mediated transepidemal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J Cntrolled Release. 1997, 485:211.
7Sodimack J, Lee R J. Targeted drug delivery via the folate receptor [ J ]. Adv. Drug Deliv Rev, 2000,41 ( 2 ) : 147.
8Nivoa K. Preparation and evaluation of a time-controlled release capsule made of EC for colon delivery of drugs[J]. J Drug Target ,1995,3(2) :83 -89.
9John T, Santini J, Michael J. A controlled-release microchip[J]. Nature, 1999,397:335 - 338.
4Sodimack J,Lee R J.Targeted drug delivery via the folate receptor.Drug Deliv Rev,2000,41(2):147.
5Furuhata M,Izumisawa T,Kawakami H,et al.Decaarginine-PEG-liposome enhanced transfection efficiency and function of arginine length and PEG.Int J Pharm,2009,371(1):40-46.
6Ishida T,Shiraga E,Kiwada H,et al.Synergistic antitumor activity of metro-nomie dosing of cyclophosphamidein combination with doxorubicin-containing PEGylated liposomes in a murine solid tumor model.J Controlled Release,2009,134(3):194-200.
7Su EH,Hyungu K,Ga YS,et al.Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.Int J Pharm,2008,353(1):260-269.
